EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

What can patients tell us in Sjögren’s syndrome?

Joe Berry, Jessica Tarn, Dennis Lendrem, John Casement, Wan-Fai Ng

Rheumatology and Immunology Research · 2024

DOI: 10.1515/rir-2024-0004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatology and Immunology Research, 2024. Verfasst von Joe Berry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Sjögren’s Syndrome (SS), clinical heterogeneity and discordance between disease activity measures and patient experience are key obstacles to effective therapeutic development. Patient reported outcome measures (PROMs) are useful tools for understanding the unmet needs from the patients’ perspective and therefore they are key for the development of patient centric healthcare systems. Initial concern about the subjectivity of PROMs has given way to methodological rigour and clear guidance for the development of PROMs. To date, several studies of patient stratification using PROMs have identified similar symptom-based subgroups. There is evidence to suggest that these subgroups may represent different disease endotypes with differing responses to therapeutic interventions. Stratified medicine approaches, alongside sensitive outcome measures, have the potential to improve our understanding of SS pathobiology and therapeutic development. The inclusion of PROMs is important for the success of such approaches. In this review we discuss the opportunities of using PROMs in understanding the pathogenesis of and therapeutic development for SS.

Schlagwörter

Stichwörter der Autor:innen

Sjögren’scomposite endpointselectronic patient-reported outcomesendotypesheterogeneitynewcastle Sjögren’s stratification toolpatient-reported outcomesstratified medicine

Autor:innen und Institutionen

  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre& NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Zitieren

APA

Berry, J., Tarn, J., Lendrem, D., Casement, J., & Ng, W. F. (2024). What can patients tell us in Sjögren’s syndrome?. Rheumatology and Immunology Research. https://doi.org/10.1515/rir-2024-0004

Vancouver

Berry J, Tarn J, Lendrem D, Casement J, Ng WF. What can patients tell us in Sjögren’s syndrome?. Rheumatology and Immunology Research. 2024. doi:10.1515/rir-2024-0004

BibTeX
@article{Berry2024,
  author = {Berry, Joe and Tarn, Jessica and Lendrem, Dennis and Casement, John and Ng, Wan-Fai},
  title = {What can patients tell us in Sjögren’s syndrome?},
  journal = {Rheumatology and Immunology Research},
  year = {2024},
  doi = {10.1515/rir-2024-0004}
}
Kostenlos starten →